The recall occurred after an internal memo from manufacturer Fresenius Medical Care (FMC) was leaked. The memo described a connection between the elevated bicarbonate levels caused by acid concentrates GranuFlo and NaturaLyte and cardiac arrest. FMS sent this memo to its own dialysis centers, but didn’t warn thousands of physicians at dialysis clinics not owned by FMC. The FDA issued a Class 1 recall on March 29, 2012.
GranuFlo Recall Help explains how this product was used in hemodialysis; possible side effects including heart attack, stroke, and metabolic alkalosis; news related to the recall; and how those hurt by the product may be eligible to file a lawsuit against GranuFlo’s manufacturer.
For more information about the GranuFlo and NaturaLyte recall, please visit the microsite or contact Hissey Kientz’s lawyers directly.